Search results for: Chronic Diseases
Filter search results
Annual Lecture 2014: Is Universal Health Coverage the Holy Grail?
19 August 2014
…concerns about the unintended consequences of the large increase in development assistance for health since the early 1990s. Most such assistance focused on specific diseases or disease areas, but neglected…
Bengt Jönsson Honoured for Contribution to Health Economics
6 August 2014
…meet specific goals such as designing a benefits package; the health economics of particular diseases, e.g. diabetes and cancer; and chapters specifically on aspects of Bengt’s contributions to the field….
Universal Health Coverage: The Holy Grail? 21st Annual Lecture Publication.
31 January 2015
…through the WHO’s slogan Health for All. Recent policies have focussed on controlling specific diseases such as HIV and malaria and delivering specific interventions such as immunisation. There is…
OHE at ISPOR Philadelphia Part 2: Risk Sharing, Medical Breakthroughs, Early Access and Drug Development Costs
12 May 2015
…be analysed. Prior registration is required. Sunday 17 May 8:00 AM – 12:00 PM Can we afford medical breakthroughs for large prevalence diseases? Lessons from hepatitis C…
LSE-ICL Medical Innovation Forum on 14th October 2015: Assessing Value and Sustainable Financing of Innovative Therapies.
29 September 2015
…“Can we afford medical breakthroughs for large prevalence diseases? Lessons from hepatitis C”. In this presentation Adrian highlights a recent example in Europe of an expensive, yet very effective, and…
Recently published: Are Wider Societal Effects Considered in Healthcare Decision-making?
29 February 2016
…by OHE’s Martina Garau, Koonal Shah, and Adrian Towse. There is evidence suggesting that, in certain diseases areas such as Alzheimer’s disease, depression, and breast cancer, health interventions can produce…
OHE Response: The National PROMs Programme Consultation
15 April 2016
…questionnaire in combination with a detailed, condition-specific measure, where available. Generic PRO data provide the crucial, common denominator with which to measure outcomes across treatments and diseases. NHS England should…
New publication: The current and future burden of late-onset dementia in the UK: estimates and interventions
10 May 2016
…more research is carried out, the better we can understand the diseases underlying dementia and work towards a treatment to slow down or stop their progression. Research is the only…
Dr Francois Maignen joins the OHE team as Head of Operational Research and Data Analysis
7 July 2016
…(NICE). He advised companies on the clinical development of new technologies in various therapeutic areas (mainly oncology, cardiovascular, neurology ad orphan diseases) both in the framework of NICE, SEED (Shaping…